6 min. Read

Letters to CMS: DMHT codes, MDPP pricing, more. Plus: Unannounced funding.

Issue 345

Welcome back to E&O: a paying subscribers-only weekly newsletter focused on three areas of health tech: FDA-regulated software devices, digital health as an employee benefit, and national virtual clinics.

Exits & Outcomes Newsletter

Here's a quick rundown of a bunch of (mostly) unannounced funding rounds plus one clinical trial update. Read on before we dig into some new comments on the proposed CMS Physician Fee Schedule for

Subscribers Only

It's a good one, too.

This digital health research is for Exits & Outcomes subscribers only. Subscribe now to read this article, get the weekly newsletter, and read through the Exits & Outcomes archives. Enter your email below to subscribe today!

Newsletters

HLTH acquisition price. Estimating Pomelo Care pricing, revenue, and more

1.09.26

7 min. Read

CMS to pay for ADHD DTx. More PFS notes. Two FDA De Novos.

11.07.25

6 min. Read

Pricing for Sword Health, Hinge Health, Joint Academy in the UK.

10.31.25

7 min. Read

Spring, Slingshot AI, Click and others write FDA about GenAI. Big Health board departs.

10.24.25

7 min. Read

Cigna clarifies new non-coverage policy for PDTs. Bevel $10M. FDA GenAI comments.

10.17.25

5 min. Read

Revisiting E&O scoops, pricing intel, revenue finds

10.10.25

7 min. Read

Big Health’s 2024 revenue shrinks. 2025: Runway worries.

9.26.25

5 min. Read

Kavira Health pricing. What did Swing Therapeutics buy? PFS Comments.

9.18.25

7 min. Read

Cerebral’s $25M M&A. Amazon-Fay. Oshi growth numbers.

9.12.25

4 min. Read

Pricing updates: Teladoc, Maven, Garner, Kaia and more

8.29.25

4 min. Read

Letters to CMS: DMHT codes, MDPP pricing, more. Plus: Unannounced funding.

Exits & Outcomes Newsletter

Subscribers Only

E&O's weekly newsletter.